These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 31912234)

  • 21. Respiratory syncytial virus hospitalization outcomes and costs of full-term and preterm infants.
    McLaurin KK; Farr AM; Wade SW; Diakun DR; Stewart DL
    J Perinatol; 2016 Nov; 36(11):990-996. PubMed ID: 27490190
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of severe disease caused by respiratory syncytial virus in children living in developed countries.
    Simoes EA; Carbonell-Estrany X
    Pediatr Infect Dis J; 2003 Feb; 22(2 Suppl):S13-8; discussion S18-20. PubMed ID: 12671448
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hospital Admission Trends for Bronchiolitis in Scotland, 2001-2016: A National Retrospective Observational Study.
    Chung A; Reeves RM; Nair H; Campbell H;
    J Infect Dis; 2020 Oct; 222(Suppl 7):S592-S598. PubMed ID: 32794556
    [TBL] [Abstract][Full Text] [Related]  

  • 24. RSV outbreak in a paediatric intensive care unit.
    Thorburn K; Kerr S; Taylor N; van Saene HK
    J Hosp Infect; 2004 Jul; 57(3):194-201. PubMed ID: 15236847
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcomes of Infants Receiving Palivizumab Prophylaxis for Respiratory Syncytial Virus in Canada and Italy: An International, Prospective Cohort Study.
    Manzoni P; Paes B; Lanctôt KL; Dall'Agnola A; Mitchell I; Calabrese S; Maule M; Girardi E; Harimoto T; Li A
    Pediatr Infect Dis J; 2017 Jan; 36(1):2-8. PubMed ID: 27649365
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SENTINEL1: An Observational Study of Respiratory Syncytial Virus Hospitalizations among U.S. Infants Born at 29 to 35 Weeks' Gestational Age Not Receiving Immunoprophylaxis.
    Anderson EJ; Krilov LR; DeVincenzo JP; Checchia PA; Halasa N; Simões EA; Domachowske JB; Forbes ML; Pannaraj PS; McBride SJ; McLaurin KK; Kumar VR; Ambrose CS
    Am J Perinatol; 2017 Jan; 34(1):51-61. PubMed ID: 27233106
    [No Abstract]   [Full Text] [Related]  

  • 27. Palivizumab prophylaxis for respiratory syncytial virus in infants with cystic fibrosis: is there a need?
    Bjornson C; Chan P; Li A; Paes B; Lanctôt KL; Mitchell I
    Eur J Clin Microbiol Infect Dis; 2018 Jun; 37(6):1113-1118. PubMed ID: 29557081
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The burden of respiratory syncytial virus bronchiolitis on a pediatric inpatient service.
    Eidelman AI; Megged O; Feldman R; Toker O
    Isr Med Assoc J; 2009 Sep; 11(9):533-6. PubMed ID: 19960846
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Burden of Respiratory Syncytial Virus Related Acute Lower Respiratory Tract Infection in Hospitalized Thai Children: A 6-Year National Data Analysis.
    Sitthikarnkha P; Uppala R; Niamsanit S; Sutra S; Thepsuthammarat K; Techasatian L; Niyomkarn W; Teeratakulpisarn J
    Children (Basel); 2022 Dec; 9(12):. PubMed ID: 36553433
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epidemiology of respiratory syncytial virus bronchiolitis in hospitalized infants in Greece.
    Tsolia MN; Kafetzis D; Danelatou K; Astral H; Kallergi K; Spyridis P; Karpathios TE
    Eur J Epidemiol; 2003; 18(1):55-61. PubMed ID: 12705624
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of the 2014 American Academy of Pediatrics Immunoprophylaxis Policy on the Rate, Severity, and Cost of Respiratory Syncytial Virus Hospitalizations among Preterm Infants.
    Krilov LR; Fergie J; Goldstein M; Brannman L
    Am J Perinatol; 2020 Jan; 37(2):174-183. PubMed ID: 31430818
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Respiratory syncytial virus hospitalization and incurred morbidities the season after prophylaxis.
    Butt ML; Elliott L; Paes BA
    Paediatr Child Health; 2018 Nov; 23(7):441-446. PubMed ID: 30374219
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost of Respiratory Syncytial Virus Infections in US Infants: Systematic Literature Review and Analysis.
    Bowser DM; Rowlands KR; Hariharan D; Gervasio RM; Buckley L; Halasa-Rappel Y; Glaser EL; Nelson CB; Shepard DS
    J Infect Dis; 2022 Aug; 226(Suppl 2):S225-S235. PubMed ID: 35968875
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Defining the Risk and Associated Morbidity and Mortality of Severe Respiratory Syncytial Virus Infection Among Preterm Infants Without Chronic Lung Disease or Congenital Heart Disease.
    Figueras-Aloy J; Manzoni P; Paes B; Simões EA; Bont L; Checchia PA; Fauroux B; Carbonell-Estrany X
    Infect Dis Ther; 2016 Dec; 5(4):417-452. PubMed ID: 27628014
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk scoring tool to predict respiratory syncytial virus hospitalisation in premature infants.
    Blanken MO; Paes B; Anderson EJ; Lanari M; Sheridan-Pereira M; Buchan S; Fullarton JR; Grubb E; Notario G; Rodgers-Gray BS; Carbonell-Estrany X
    Pediatr Pulmonol; 2018 May; 53(5):605-612. PubMed ID: 29405612
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Global disease burden of and risk factors for acute lower respiratory infections caused by respiratory syncytial virus in preterm infants and young children in 2019: a systematic review and meta-analysis of aggregated and individual participant data.
    Wang X; Li Y; Shi T; Bont LJ; Chu HY; Zar HJ; Wahi-Singh B; Ma Y; Cong B; Sharland E; Riley RD; Deng J; Figueras-Aloy J; Heikkinen T; Jones MH; Liese JG; Markić J; Mejias A; Nunes MC; Resch B; Satav A; Yeo KT; Simões EAF; Nair H; ;
    Lancet; 2024 Mar; 403(10433):1241-1253. PubMed ID: 38367641
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Respiratory syncytial virus infection and disease in infants and young children observed from birth in Kilifi District, Kenya.
    Nokes DJ; Okiro EA; Ngama M; Ochola R; White LJ; Scott PD; English M; Cane PA; Medley GF
    Clin Infect Dis; 2008 Jan; 46(1):50-7. PubMed ID: 18171213
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Respiratory syncytial virus infection in high risk infants and the potential impact of prophylaxis in a United Kingdom cohort.
    Clark SJ; Beresford MW; Subhedar NV; Shaw NJ
    Arch Dis Child; 2000 Oct; 83(4):313-6. PubMed ID: 10999865
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Respiratory syncytial virus prophylaxis in infants with congenital airway anomalies compared to standard indications and complex medical disorders.
    Paes B; Kim D; Saleem M; Wong S; Mitchell I; Lanctot KL;
    Eur J Pediatr; 2019 Mar; 178(3):377-385. PubMed ID: 30610419
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Respiratory Syncytial Virus Preterm (32-36 Completed Weeks of Gestation) Risk Estimation Measure for RSV Hospitalization in Ireland: A Prospective Study.
    Sheridan-Pereira M; Murphy J; Sloan J; Crispino G; Leahy A; Corcoran JD; Dempsey E; Elnazir B; Gavin P; Sharif F; Gul R; Satas S; Murphy J; Gormally S; Shanaa I; Waldron D; Mc Mahon P; Carson J; Blanken M; Bont L; Paes B
    Pediatr Infect Dis J; 2016 Jan; 35(1):19-24. PubMed ID: 26379160
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.